肠易激综合征
医学
肠功能
胃肠病学
益生菌
炎症性肠病
内科学
重症监护医学
炎症性肠病
细菌
遗传学
生物
疾病
标识
DOI:10.1016/s1590-8658(07)60007-3
摘要
This brief review appraises the current evidence of the efficacy of probiotics, including lactobacilli, bifidobacteria, and VSL#3, in the treatment of irritable bowel syndrome (IBS). The mechanisms potentially important will be evaluated, with specific reference to immune function, effects on motility and intraluminal milieu. These experimental and clinical observations suggest that probiotics may play a role in the management of IBS.
科研通智能强力驱动
Strongly Powered by AbleSci AI